Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- DOUBLE HELIX OPTICS, INC.
- Proposal award date
- 2020-06-01
- Contract end date
- 2020-11-30
- UEI
- UV6KRAFL8LJ2
- Solicitation number
- PA18-574
- Topic code
- NIBIB
Research abstract
Summary
This Small Business Innovation Research (SBIR) Phase I project is focused on the design, development, and
testing of a ground-breaking multidimensional multifunctional quantitative optical microscopy module suitable for
live whole cell studies. The module will utilize Light Engineering to achieve fast high-sensitivity, low-noise, high-
resolution measurements down to the single-molecule level while providing wide volumetric field of view.
In spite of the ongoing revolution in optical microscopy, the availability of state-of-the-art commercial solutions
has been slow to market, lacking in flexibility, ease of access and affordability.
The proposed instrument is based on an integrated design of the illumination, 3D optical response, data
collection, and reconstruction algorithms for fluorescence imaging. Specifically, engineered 3D light excitation
limits the background noise while reducing photo-damage and photo-toxicity. The engineering of the 3D point
spread function enables multiplex functionality including an extended depth of field, high-sensitivity 3D
localization of single-molecules or cellular heterogeneities, multi-color, and 3D imaging. The integrated system
will enable reconstruction with superb sectioning capability. As a result, the target performance metrics,
supported by recent research demonstrations in academic labs, outperform the state of the art in terms of
spatial/temporal resolution, signal-to-noise ratio, field of view, and ease of use.
This SBIR project is targeted towards commercialization of a cost-effective solution that can be easily integrated
with existing scientific microscopes. The commercial module, to be developed from the Phase I prototype, will
include a small footprint architecture, a set of novel optical phase masks for point spread function engineering
and excitation shaping, a robust optomechanical design, and real-time experiment control software. Tests of the
instrument in significant biomedical problems at partners’ labs will validate end-user acceptance and provide
valuable feedback towards commercialization.
The implications in biomedical imaging are far-reaching. For instance, the instrument would benefit the study of
oncogenesis, owing to its degree of molecular sensitivity for detecting the spatial localization of receptors and
other signaling molecules within the tumor/extracellular matrix. It would also empower the study of degenerative
diseases where the instrument can help reveal their molecular origin and develop novel therapeutic strategies.
The new imaging capabilities could further assist in stem cell and brain research.
Double Helix Optics is a startup company with a proven record and exclusive licensing rights to the Light
Engineering technology from the University of Colorado, as well as the novel Tetrapod and Multicolor PSF
localization developments from Stanford University. The company, headquartered in the BioFrontiers Institute in
Boulder, is optimally positioned to successfully bring this product to market.Project Narrative:
We propose to develop a highly innovative Light Engineering module for fast high-resolution whole-cell
imaging. Easy to install onto standard microscopes that exists in thousands of laboratories across the U.S., this
module will include compact robust optomechanical design, novel optical phase masks for point spread
function engineering and excitation shaping, and real-time experiment control software. Such a module will
outperform the current state of the art and allow scientists to easily study dynamic cellular processes without
damaging the cell, thus allowing, for instance, new insights into the complex relation between cell-extracellular
matrix interactions and degenerative diseases.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
8 SBIR/STTR records share this UEI (2013–2025). Reported award amounts total $4,806,540. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services, National Science Foundation
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards